Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Apr;24(4):250-263.
doi: 10.1038/s41577-023-00941-2. Epub 2023 Sep 28.

Immunological factors linked to geographical variation in vaccine responses

Affiliations
Review

Immunological factors linked to geographical variation in vaccine responses

Marloes M A R van Dorst et al. Nat Rev Immunol. 2024 Apr.

Abstract

Vaccination is one of medicine's greatest achievements; however, its full potential is hampered by considerable variation in efficacy across populations and geographical regions. For example, attenuated malaria vaccines in high-income countries confer almost 100% protection, whereas in low-income regions these same vaccines achieve only 20-50% protection. This trend is also observed for other vaccines, such as bacillus Calmette-Guérin (BCG), rotavirus and yellow fever vaccines, in terms of either immunogenicity or efficacy. Multiple environmental factors affect vaccine responses, including pathogen exposure, microbiota composition and dietary nutrients. However, there has been variable success with interventions that target these individual factors, highlighting the need for a better understanding of their downstream immunological mechanisms to develop new ways of modulating vaccine responses. Here, we review the immunological factors that underlie geographical variation in vaccine responses. Through the identification of causal pathways that link environmental influences to vaccine responsiveness, it might become possible to devise modulatory compounds that can complement vaccines for better outcomes in regions where they are needed most.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Li, X., Mukandavire, C. & Cucunuba, Z. M. Estimating the health impact of vaccination against ten pathogens in 98 low-income and middle-income countries from 2000 to 2030: a modelling study. Lancet 397, 398–408 (2021). - PubMed - PMC - DOI
    1. Fine, P. E. M. Variation in protection by BCG-implications of and for heterologous immunity. Lancet 346, 1339–1345 (1995). This publication is the first to address the impact of environmental factors on variation in BCG vaccine efficacy. - PubMed - DOI
    1. Vesikari, T. et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet 370, 1757–1763 (2007). - PubMed - DOI
    1. Madhi, S. A. et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N. Engl. J. Med. 362, 289–298 (2010). - PubMed - DOI
    1. Clark, A. et al. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials. Lancet Infect. Dis. 19, 717–727 (2019). This publication is a meta-analysis of trials across the world showing that rotavirus vaccine efficacy and durability are lowest in countries with highest child mortality. - PubMed - PMC - DOI

LinkOut - more resources